Last reviewed · How we verify
NCT07460700: MESMARK
Mesenteric Ischemia Markers Study
NA trial testing Blood samples in Mesenteric Vascular Disease in 120 participants. Currently enrolling.
12 August 2026
Quick facts
| Lead sponsor | Belarusian State Medical University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 120 |
| Start date | 22 December 2025 |
| Primary completion | 12 August 2026 |
| Estimated completion | 12 December 2026 |
| Sites | 1 location across Belarus |
Drugs / interventions tested
- Blood samples — full drug profile →
Conditions studied
- Mesenteric Vascular Disease — all drugs for Mesenteric Vascular Disease →
Sponsor
Belarusian State Medical University
Who can join
18 and older, any sex, with Mesenteric Vascular Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Vascular bowel disease remains a socially significant and potentially fatal condition (if it develops into AMI), primarily due to delayed diagnosis. Blood biomarkers are theoretically ideal for early risk stratification (like troponins in myocardial infarction). However, the existing evidence base is characterized by low quality and high heterogeneity, which hinders their use in clinical practice. Therefore, there is an urgent and unmet clinical need for high-quality, methodologically rigorous research to validate biomarkers in MI. A current study (MESMARK) is to be undertaken to identify combinations of biomarkers that can reliably identify mesenteric ischemia (MI) and distinguish between non-transmural and transmural clinical relevant ischemia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07460700
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Blood samples
Trials testing the same drug.
- NCT06996249 — Prospective Data Collection Initiative on Thoracic Malignancies · recruiting
- NCT06694363 — New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome · recruiting
- NCT06826066 — Involvement of the Immune System in Intrinsic Radiosensitivity · NA · recruiting
- NCT06864481 — Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis · recruiting
- NCT06602934 — Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneu · NA · recruiting
Other recruiting trials for Mesenteric Vascular Disease
Currently open trials in the same condition.
- NCT07486570 — Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery · NA · recruiting
Other Belarusian State Medical University trials
Trials by the same sponsor.
- NCT05323669 — Molecular Profile of Thyroid Nodules · unknown
- NCT05122195 — Graduated Elastic compRession for vAricose Veins in PrEgnancy · unknown
- NCT04096729 — Patients Commitment to Compression Therapy · completed
- NCT04434274 — MIcronized Flavonoid Fraction After MechanO-Chemical Ablation · unknown
- NCT04441957 — MechanO-Chemical Ablation Versus CompreSSion · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07460700 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Belarusian State Medical University
- Last refreshed: 10 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07460700.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing